23andMe cuts 40% of its workforce, discontinues all therapy …
1 day ago · After Monday’s restructuring plan, the company expects annualized cost savings of more than $35 million. Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees ...
23andMe cuts 40% of its workforce, discontinues all therapy …
1 day ago · In This Article: (Reuters) -Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as ...
The end of 23andMe’s drug discovery dream - STAT
1 day ago · Anne Wojcicki is the CEO and co-founder of 23andMe. Emma McIntyre/Getty Images for MAKERS. By Matthew Herper. Nov. 11, 2024. ... All the health and medical news you need today, in one email.
23andMe Announces Business Restructuring to Streamline …
1 day ago · Premium News. Economics. Housing. Earnings. ... of our core consumer business and research partnerships,” said Anne Wojcicki, 23andMe’s CEO, Co-Founder, and Chair of the Board ...
DNA-testing site 23andMe to lay off 40% of its workers
1 day ago · João da Silva. The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival. The once-popular DNA-testing site will also halt work ...
23andMe announces 40% layoffs, ends therapeutics division
1 day ago · This left Wojcicki as the only remaining board member. For the quarter ending June 30, 23andMe posted a loss of $69.4 million on revenue of $40.4 million. Advertisement
23andMe to slash 40% of its workforce, end therapeutics
1 day ago · By Mike Murphy. DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company ...
23andMe Announces Business Restructuring to Streamline …
1 day ago · SUNNYVALE, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing further development of all its therapeutics programs, while evaluating strategic alternatives ...
DNA-testing site 23andMe fights for survival - BBC
Nov 5, 2024 · Getty Images. Three years ago, the DNA-testing firm 23andMe was a massive success, with a share price higher than Apple's. But, from those heady days of millions of people rushing to send it ...
23andMe shutters cancer drug research, lays off 40% of staff
1 day ago · 23andMe layoffs Cancer Anne Wojcicki. 23andMe is shutting down its therapeutics development division, and plans to seek out buyers to find a new home for its in-house pipeline of DNA-informed ...
- Some results have been removed